Inspire Medical Systems, Inc. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
Inspire Medical Systems, Inc. (INSP) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $4.33 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2025-11-03.
Financial Statements › Notes › Equity
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-02-13
- Inspire Medical Systems, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2024-09-30 was $4.33M, a 740.12% increase year-over-year.
- Inspire Medical Systems, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2024-06-30 was $1.86M, a 91.76% increase year-over-year.
- Inspire Medical Systems, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2024-03-31 was $2.85M, a 63.12% increase year-over-year.
- Inspire Medical Systems, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2023-09-30 was $516.00K.
- Inspire Medical Systems, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $17.16M, a 39802.33% increase from fiscal 2022.
- Inspire Medical Systems, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $43.00K.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2024-09-30 | $4.33M 10-Q · filed 2025-11-03 | $6.20M derived: sum of 2 quarters · filed 2025-11-03 | $9.04M derived: sum of 3 quarters · filed 2025-11-03 | |
| 2024-06-30 | $1.86M 10-Q · filed 2025-11-03 | $4.71M derived: sum of 2 quarters · filed 2025-11-03 | ||
| 2024-03-31 | $2.85M 10-Q · filed 2025-11-03 | |||
| 2023-12-31 | $17.16M 10-K · filed 2026-02-13 | |||
| 2023-09-30 | $516.00K 10-Q · filed 2024-11-04 | $1.49M derived: sum of 2 quarters · filed 2024-11-04 | $3.23M derived: sum of 3 quarters · filed 2024-11-04 | |
| 2023-06-30 | $971.00K 10-Q · filed 2024-11-04 | $2.72M derived: sum of 2 quarters · filed 2024-11-04 | ||
| 2023-03-31 | $1.75M 10-Q · filed 2024-11-04 | |||
| 2022-12-31 | $43.00K 10-K · filed 2025-02-10 | |||
| 2022-03-31 | $43.00K 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |